DOX Quote, Financials, Valuation and Earnings

Sabre has a net margin of 14.47% compared to Amdocs's net margin of 4.55%. Amdocs's return on equity of 15.34% beat Sabre's return on equity of --.

Amdocs has a consensus price target of $101.69, signalling upside risk potential of 11.22%. On the other hand Sabre has an analysts' consensus of $4.58 which suggests that it could grow by 79.9%. Given that Sabre has higher upside potential than Amdocs, analysts believe Sabre is more attractive than Amdocs.

Amdocs has a beta of 0.506, which suggesting that the stock is 49.442% less volatile than S&P 500. In comparison Sabre has a beta of 1.330, suggesting its more volatile than the S&P 500 by 32.971%.

Amdocs has a quarterly dividend of $0.53 per share corresponding to a yield of 2.15%. Sabre offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. Sabre pays out -- of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.1B, which are larger than Sabre quarterly revenues of $776.6M. Amdocs's net income of $163.2M is higher than Sabre's net income of $35.3M. Notably, Amdocs's price-to-earnings ratio is 19.23x while Sabre's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 2.15x versus 0.34x for Sabre. Usually stocks with elevated PS ratios are considered overvalued.

Signing Day Sports has a net margin of 14.47% compared to Amdocs's net margin of -568.22%. Amdocs's return on equity of 15.34% beat Signing Day Sports's return on equity of --.

Amdocs has a consensus price target of $101.69, signalling upside risk potential of 11.22%. On the other hand Signing Day Sports has an analysts' consensus of -- which suggests that it could fall by --. Given that Amdocs has higher upside potential than Signing Day Sports, analysts believe Amdocs is more attractive than Signing Day Sports.

Amdocs has a beta of 0.506, which suggesting that the stock is 49.442% less volatile than S&P 500. In comparison Signing Day Sports has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Amdocs has a quarterly dividend of $0.53 per share corresponding to a yield of 2.15%. Signing Day Sports offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. Signing Day Sports pays out -- of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.1B, which are larger than Signing Day Sports quarterly revenues of $148.4K. Amdocs's net income of $163.2M is higher than Signing Day Sports's net income of -$843K. Notably, Amdocs's price-to-earnings ratio is 19.23x while Signing Day Sports's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 2.15x versus 1.06x for Signing Day Sports. Usually stocks with elevated PS ratios are considered overvalued.

Twilio has a net margin of 14.47% compared to Amdocs's net margin of 1.71%. Amdocs's return on equity of 15.34% beat Twilio's return on equity of -0.4%.

Amdocs has a consensus price target of $101.69, signalling upside risk potential of 11.22%. On the other hand Twilio has an analysts' consensus of $128.80 which suggests that it could grow by 13.49%. Given that Twilio has higher upside potential than Amdocs, analysts believe Twilio is more attractive than Amdocs.

Amdocs has a beta of 0.506, which suggesting that the stock is 49.442% less volatile than S&P 500. In comparison Twilio has a beta of 1.438, suggesting its more volatile than the S&P 500 by 43.816%.

Amdocs has a quarterly dividend of $0.53 per share corresponding to a yield of 2.15%. Twilio offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. Twilio pays out -- of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.1B, which are smaller than Twilio quarterly revenues of $1.2B. Amdocs's net income of $163.2M is higher than Twilio's net income of $20M. Notably, Amdocs's price-to-earnings ratio is 19.23x while Twilio's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 2.15x versus 3.99x for Twilio. Usually stocks with elevated PS ratios are considered overvalued.

WidePoint has a net margin of 14.47% compared to Amdocs's net margin of -2.12%. Amdocs's return on equity of 15.34% beat WidePoint's return on equity of -14.61%.

Amdocs has a consensus price target of $101.69, signalling upside risk potential of 11.22%. On the other hand WidePoint has an analysts' consensus of $7.50 which suggests that it could grow by 148.34%. Given that WidePoint has higher upside potential than Amdocs, analysts believe WidePoint is more attractive than Amdocs.

Amdocs has a beta of 0.506, which suggesting that the stock is 49.442% less volatile than S&P 500. In comparison WidePoint has a beta of 1.805, suggesting its more volatile than the S&P 500 by 80.475%.

Amdocs has a quarterly dividend of $0.53 per share corresponding to a yield of 2.15%. WidePoint offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. WidePoint pays out -- of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.1B, which are larger than WidePoint quarterly revenues of $34.2M. Amdocs's net income of $163.2M is higher than WidePoint's net income of -$724.1K. Notably, Amdocs's price-to-earnings ratio is 19.23x while WidePoint's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 2.15x versus 0.20x for WidePoint. Usually stocks with elevated PS ratios are considered overvalued.